bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.235
-0.035 (-2.76%)
Nov 21, 2024, 4:00 PM EST - Market closed
bioAffinity Technologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 19 | 14 | 13 | - | - |
Market Cap Growth | 174.53% | 4.34% | - | - | - |
Enterprise Value | 21 | 11 | 1 | - | - |
Last Close Price | 1.27 | 1.47 | 1.60 | - | - |
PS Ratio | 1.46 | 5.52 | 2788.17 | - | - |
PB Ratio | 5.04 | 2.88 | 1.21 | - | - |
P/TBV Ratio | 30.28 | 5.34 | 1.21 | - | - |
EV/Sales Ratio | 2.22 | 4.40 | 147.57 | - | - |
Debt / Equity Ratio | 0.55 | 0.33 | 0.02 | -0.97 | -0.91 |
Asset Turnover | 1.12 | 0.25 | 0.00 | - | - |
Inventory Turnover | 345.12 | 144.93 | - | - | - |
Quick Ratio | 0.84 | 1.62 | 10.03 | 0.10 | 0.01 |
Current Ratio | 1.02 | 1.77 | 10.50 | 0.11 | 0.01 |
Return on Equity (ROE) | -167.00% | -99.84% | - | - | - |
Return on Assets (ROA) | -62.34% | -48.85% | -36.77% | -172.53% | - |
Return on Capital (ROIC) | -77.19% | -56.22% | -45.94% | - | - |
Earnings Yield | -42.67% | -56.80% | -60.89% | - | - |
FCF Yield | -43.37% | -32.04% | - | - |
Buyback Yield / Dilution | -26.38% | -94.43% | -68.17% | -0.02% | - |
Total Shareholder Return | -26.38% | -94.43% | -68.17% | -0.02% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.